Cite
HARVARD Citation
Kulasekararaj, A. et al. (n.d.). P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS. HemaSphere. pp. 706-707. [Online].